Shenzhen Lifotronic Technology Co., Ltd. (SHA:688389)

Market Cap	5.85B -3.8%
Revenue (ttm)	1.05B -11.7%
Net Income	251.02M -34.1%
EPS	0.59 -33.8%
Shares Out	428.49M
PE Ratio	23.19
Forward PE	19.78
Dividend	0.28 (2.07%)
Ex-Dividend Date	May 23, 2025

Volume	2,163,075
Average Volume	3,252,500
Open	13.74
Previous Close	13.71
Day's Range	13.59 - 13.81
52-Week Range	12.45 - 16.53
Beta	0.46
RSI	45.39
Earnings Date	Apr 23, 2026

About SHA:688389

Shenzhen Lifotronic Technology Co., Ltd. research, develops, manufactures, and markets medical devices for diagnostics, therapy, clinical medicine, skin, and human health related purposes in China. The company offers IVD products, such as HPLC, ECLIA, and hematology system; rapid test, molecular and POCT diagnostics. It also offers therapeutic products comprising respiratory and ICU, and wound care; electromagnetic and pneumatic shockwave products. In addition, the company provides medical and aesthetic, and laser hair removal products, as well...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2008
• Employees: 1,658
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688389

Financial Performance

In 2024, SHA:688389's revenue was 1.15 billion, an increase of 0.20% compared to the previous year's 1.15 billion. Earnings were 345.39 million, an increase of 5.12%.